Calcium mass balance in adults during single hemodialysis and hemodiafiltration treatments using lower calcium dialysate concentrations.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Chhabra R;Chhabra R; Davenport A; Davenport A
  • Source:
    Artificial organs [Artif Organs] 2024 Aug; Vol. 48 (8), pp. 812-820. Date of Electronic Publication: 2024 Jun 04.
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7802778 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1594 (Electronic) Linking ISSN: 0160564X NLM ISO Abbreviation: Artif Organs Subsets: MEDLINE
    • Publication Information:
      Publication: Cambridge, MA : Wiley-Blackwell
      Original Publication: Cleveland, International Society for Artificial Organs.
    • Subject Terms:
    • Abstract:
      Background: Debate continues as to the optimum hemodialysis (HD) dialysate calcium concentration. Although current guidelines advocate 1.25-1.5 mmol/L, some investigators have suggested these may cause calcium gains. As such we investigated whether using dialysate calcium of 1.25 mmol/L risked calcium gains, and whether there were differences between hemodiafiltration and high flux HD.
      Methods: We continuously collect an aliquot of effluent dialysate during dialysis sessions, and calculated dialysis calcium mass balance by the difference between the amount of calcium delivered as fresh dialysate and that lost in effluent dialysate.
      Results: We studied 106 stable outpatients, 64% male, mean age 64.4 ± 16.2 years, median dialysis vintage 32 (22-60) months. Most sessions (69%) used a 1.0 mmol/L calcium dialysate, with a median sessional loss of 13.7 (11.5-17.1) mmol, whereas using 1.25 mmol/L the median loss was 7.4 (4.9-10.1) mmol, but with 6.9% had a positive balance (p = 0.031 vs dialysate calcium 1.0 mmol/L). Most patients (85.8%) were treated by hemodiafiltration, but there was no difference in sessional losses (11.7 (8.4-15.8) vs 13.5 (8.1-16.8)) with high flux HD. Dialysis sessional calcium balance was associated with the use of lower dialysate calcium concentration (β -19.5, 95% confidence limits (95%CL) -27.7 to -11.3, p < 0.001), and sessional duration (β 0.07 (95% CL) 0.03-012, p = 0.002).
      Conclusion: Ideally, the choice of dialysate calcium should be individualized, but clinicians should be aware, that even when using a dialysate calcium of 1.25 mmol/L, some patients are at risk of a calcium gain during hemodiafiltration and high-flux hemodialysis.
      (© 2024 The Author(s). Artificial Organs published by International Center for Artificial Organ and Transplantation (ICAOT) and Wiley Periodicals LLC.)
    • References:
      Evenepoel P, Jørgensen H, Bover J, Davenport A, Bacchetta J, Haarhaus M, et al. The recommended calcium intake in children and adults with CKD across stages of disease—a European consensus statement. Nephrol Dial Transplant. 2024;39(2):341–366.
      Matikainen N, Pekkarinen T, Ryhänen EM, Schalin‐Jäntti C. Physiology of calcium homeostasis: an overview. Endocrinol Metab Clin N Am. 2021;50(4):575–590.
      Jaques DA, Henderson S, Davenport A. Association between bone mineral density at different anatomical sites and both mortality and fracture risk in patients receiving renal replacement therapy: a longitudinal study. Clin Kidney J. 2022;15(6):1188–1195.
      Drueke TB, Touam M. Calcium balance in haemodialysis—do not lower the dialysate calcium concentration too much (con part). Nephrol Dial Transplant. 2009;24:2990–2993.
      van der Sande FM, Ter Meulen KJA, Kotanko P, Kooman JP. Dialysate calcium levels: do they matter? Blood Purif. 2019;47(1–3):230–235.
      Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, et al. Executive summary of the 2017 KDIGO chronic kidney disease‐mineral and bone disorder (CKD‐MBD) guideline update: what's changed and why it matters. Kidney Int. 2017;92(1):26–36.
      Gotch FA, Kotanko P, Thijssen S, Levin NW. The KDIGO guideline for dialysate calcium will result in an increased incidence of calcium accumulation in hemodialysis patients. Kidney Int. 2010;78(4):343–350.
      Basile C, Libutti P, Lomonte C. The diffusion gradient between the ionized calcium concentration in the dialysate and in the blood is the main driving force of the net calcium mass balance during haemodialysis. Nephrol Dial Transplant. 2010;25(4):1356–1357.
      Tattersall JE, Ward RA, EUDIAL group. Online haemodiafiltration: definition, dose quantification and safety revisited. Nephrol Dial Transplant. 2013;28(3):542–550.
      Davenport A. Potential adverse effects of replacing high volume hemofiltration exchanges on electrolyte balance and acid‐base status using the current commercially available replacement solutions in patients with acute renal failure. Int J Artif Organs. 2008;31(1):3–5.
      Davies SJ, Phillips L, Naish PF, Russell GI. Quantifying comorbidity in peritoneal dialysis patients and its relationship to other predictors of survival. Nephrol Dial Transplant. 2002;17(6):1085–1092.
      Walker SR, Brar R, Eng F, Komenda P, Rigatto C, Prasad B, et al. Frailty and physical function in chronic kidney disease: the CanFIT study. Can J Kidney Health Dis. 2015;2:32. https://doi.org/10.1186/s40697‐015‐0067‐4.
      Tangvoraphonkchai K, Riddell A, Davenport A. Platelet activation and clotting cascade activation by dialyzers designed for high volume online hemodiafiltration. Hemodial Int. 2018;22(2):192–200.
      Ekbal NJ, Consalus A, Persaud J, Davenport A. Reliability of delivered dialysate sodium concentration. Hemodial Int. 2016;20 Suppl 1:S2–S6.
      Bourguignon C, Dupuy AM, Coste T, Michel F, Cristol JP. Evaluation of NM‐BAPTA method for plasma total calcium measurement on Cobas 8000®. Clin Biochem. 2014;47(7–8):636–639.
      Depner TA, Daugirdas JT. Equations for normalized protein catabolic rate based on two‐point modelling of haemodialysis urea kinetics. J Am Soc Nephrol. 1996;7(5):780–785.
      Basile C, Libutti P, De Turo AL, Casucci F, Losurdo N, Teutonico A, et al. Effects of different dialysate calcium concentrations on intra‐dialysis hemodynamic stability. J Nephrol. 2012;25(4):506–514.
      Waniewski J, Debowska M, Wojcik‐Zaluska A, Ksiazek A, Zaluska W. Correction: quantification of dialytic removal and extracellular calcium mass balance during a weekly cycle of hemodialysis. PLoS One. 2018;13(2):e0193604.
      Basile C. Calcium mass balances in bicarbonate hemodialysis. Int J Nephrol. 2011;2011:540592.
      Bosticardo G, Malberti F, Basile C, Leardini L, Libutti P, Filiberti O, et al. Optimizing the dialysate calcium concentration in bicarbonate haemodialysis. Nephrol Dial Transplant. 2012;27(6):2489–2496.
      Argilés A, Mion CM. Calcium balance and intact PTH variations during haemodiafiltration. Nephrol Dial Transplant. 1995;10(11):2083–2089.
      Uchino S, Cole L, Morimatsu H, Goldsmith D, Ronco C, Bellomo R. Solute mass balance during isovolaemic high volume hemofiltration. Intensive Care Med. 2003;9:1541–1546.
      Brunelli SM, Sibbel S, Do TP, Cooper K, Bradbury BD. Facility dialysate calcium practices and clinical outcomes among patients receiving hemodialysis: a retrospective observational study. Am J Kidney Dis. 2015;66(4):655–665.
      Vareesangthip K, Davenport A. Reducing the risk of intradialytic hypotension by altering the composition of the dialysate. Hemodial Int. 2020;24(3):276–281.
      Kyriazis J, Kalogeropoulou K, Bilirakis L, Smirnioudis N, Pikounis V, Stamatiadis D, et al. Dialysate magnesium level and blood pressure. Kidney Int. 2004;66(3):1221–1231.
      Pun PH, Horton JR, Middleton JP. Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. Clin J Am Soc Nephrol. 2013;8(5):797–803.
    • Contributed Indexing:
      Keywords: alfacalcidol; calcium; hemodiafiltration; hemodialysis; phosphate binder
    • Accession Number:
      SY7Q814VUP (Calcium)
      0 (Dialysis Solutions)
      0 (Hemodialysis Solutions)
    • Publication Date:
      Date Created: 20240605 Date Completed: 20240722 Latest Revision: 20240722
    • Publication Date:
      20240722
    • Accession Number:
      10.1111/aor.14802
    • Accession Number:
      38837801